A Fed interest rate cut is in the bag. What then?
U.S. central bankers are expected to lower borrowing costs this week for the first time since the depths of the financial crisis more than a...
Asian shares drift into trade talks, Fed test
Asian shares drifted lower on Monday as markets anxiously counted down to a likely cut in U.S. interest rates this week with much riding on...
Asian shares guarded as investors count down to Fed
Asian shares got off to a cautious start on Monday as markets count down to a likely cut in U.S. interest rates this week with...
As rural India develops taste for chocolate, a dominant Mondelez extends its reach
Two years ago, Satish P., a bakery owner in the small village of Harohalli near Bengaluru, had his doubts about stocking Mondelez’s Cadbury Silk bars....
U.S., China move trade talks to Shanghai amid deal pessimism
U.S. and Chinese trade negotiators shift to Shanghai this week for their first in-person talks since a G20 truce last month, a change of scenery...
Exclusive: BlackRock in talks to take over Cofense after U.S. security concerns – sources
BlackRock Inc , an investor in Cofense Inc, is in advanced talks to take over the U.S. cyber security firm, after a U.S. national security...
LSE-Refinitiv deal faces long antitrust review: sources
U.S. buyout fund Blackstone Group Inc is expected to announce the merger of its majority-owned financial data firm Refinitiv with the London Stock Exchange Group...
SABIC CEO says no interest in taking over Clariant
Saudi Basic Industries Corp (SABIC) has no interest in taking over Swiss chemicals firm Clariant and considers its 25% stake in the company as “a...
LSE’s bid for Refinitiv spotlights quest for data, globality
London Stock Exchange Group Plc’s planned purchase of Refinitiv in a $27 billion deal is the latest sign that exchange operators are focusing more on...
Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg
Cancer diagnostics company Exact Sciences Corp is in advanced negotiations to buy healthcare company Genomic Health Inc for about $2.8 billion to strengthen its cancer...